Top Markets
Coin of the day
Aker BioMarine AS Aker BioMarine AS

Aker BioMarine AS

AKBM
株式のランク #8735
Aker BioMarine AS, a subsidiary of Aker ASA, is a Norwegian company established... Aker BioMarine AS, a subsidiary of Aker ASA, is a Norwegian company established in 2006 and headquartered in Lysaker. The firm is dedicated to the global development, production, and commercialization of ingredients sourced from krill, serving diverse applications in nutraceuticals, dietary supplements, and animal feed. Its market reach extends across Norway, the Americas, Asia Pacific, Europe, the Middle East, and Africa. The company operates through two distinct segments: Ingredients and Brands. Its product portfolio features Superba, a krill-derived nutraceutical ingredient recognized for its phospholipid complex containing choline, omega-3s, and astaxanthin. Other key offerings include QRILL Aqua, designed for aquaculture, and QRILL Pet, tailored for animal feed. Aker BioMarine also provides LYSOVETA, an innovative delivery platform based on LPC-bound EPA and DHA from krill, alongside INVI, a hydrolyzed protein isolate suitable for food and beverage applications. Beyond its core ingredient business, the company distributes natural supplements and various human health and nutrition products. Furthermore, it oversees AION, a circular solutions provider focused on waste recycling and material reuse.
株価
$13.48
最終同期: 2026-08-28
時価総額
$1.18B
変化(1日)
-0.92%
変化(1年)
59.71%
NO
取引 Aker BioMarine AS (AKBM)

カテゴリー

Aker BioMarine AS(AKBM)の利益
2026 時点の利益 TTM: 0
Aker BioMarine AS の最新の財務報告によると、同社の現在の利益は 0 です。2026 年には 0 の利益を上げ、これは 2026 年の利益 0 と 同等 です。このページに表示されている利益は、利息および税引き前利益、すなわち EBIT です。
Aker BioMarine AS の利益の推移(2026 〜 2026)
各年末の利益
利益 変化
提供された日付のデータは十分ではありません。
同業他社の利益
企業 利益 利益の差
$12.96B -
CH
- -
FR
- -
JP
$550.06M -
IN
- -
BR